张丹参, 任雷鸣. 腺苷A1受体阻断剂对学习记忆的影响及机制分析腺苷A1受体阻断剂对学习记忆的影响及机制分析J. 药学学报, 2003, 38(6): 416-419.
引用本文: 张丹参, 任雷鸣. 腺苷A1受体阻断剂对学习记忆的影响及机制分析腺苷A1受体阻断剂对学习记忆的影响及机制分析J. 药学学报, 2003, 38(6): 416-419.
ZHANG Dan-shen, REN Lei-ming. Effect of adenosine A1 receptor antagonist on learning and memory and analysis of its mechanismJ. Acta Pharmaceutica Sinica, 2003, 38(6): 416-419.
Citation: ZHANG Dan-shen, REN Lei-ming. Effect of adenosine A1 receptor antagonist on learning and memory and analysis of its mechanismJ. Acta Pharmaceutica Sinica, 2003, 38(6): 416-419.

腺苷A1受体阻断剂对学习记忆的影响及机制分析腺苷A1受体阻断剂对学习记忆的影响及机制分析

Effect of adenosine A1 receptor antagonist on learning and memory and analysis of its mechanism

  • 摘要: 目的探讨腺苷A1受体阻断剂对学习记忆的影响及其与胆碱能、氨基酸能神经的关系。方法采用避暗实验、分光光度法和HPLC法,观察腺苷A1受体特异性阻断剂8-环戊-1,3-二丙基黄嘌呤(DPCPX)对东莨菪碱(Scop)、2-氨基-5-磷戊酸(AP5)致小鼠记忆障碍及脑胆碱酯酶(AChE)活性、氨基酸水平的影响。结果DPCPX可显著改善Scop致记忆障碍,但对AP5致记忆障碍无影响;在体内外高剂量DPCPX可显著抑制小鼠脑AChE活性;DPCPX icv可显著升高小鼠脑Glu和Asp含量,降低GABA含量,使脑内Glu/GABA比值显著升高。结论腺苷A1受体特异性阻断剂DPCPX可显著改善Scop而不能改善AP5致记忆障碍,在高剂量时可影响脑AChE活性和脑氨基酸水平、升高脑内Glu/GABA比值。

     

    Abstract: AimTo study the effect of blocking adenosine A1 receptors on learning and memory and the relation with cholinergic and aminoacidergic nerve. Methods Using step through test, spectrophotometry and HPLC mothod, the effect of selective adenosine A1 receptor antagonist 8-cyclopentyl-1,3-dipropylxanthine (DPCPX, 0.3, 0.15, 0.075, 0.03, 0.015 μg, icv) on memory impairment by scopolamine(Scop, 3 mg·kg-1 ip) or 2-amino-5-phosphonovaleric(AP5, 2.5 ng, icv), acetylcholinesterase(AChE) activity and aminoacid level in brain of mice was studied. Results DPCPX was shown to significantly improve scopolamine-induced memory impairment, but not AP5-induced. The activity of AChE in mouse brain was significantly inhibited by large doses of DPCPX in vitro andin vivo test. DPCPX(0.3 μg, icv) was shown to significantly increase the content of glutamate and aspartic acid in brain of mice. DPCPX (0.3, 0.15μg, icv) significantly decrease GABA and increase Glu/GABA in brain of mice. Conclusion The selective adenosine A1 receptor antagonist DPCPX was shown to significantly improve scopolamine but not AP5-induced memory impairment. Large doses of DPCPX was shown to influence the AChE activity and the changes in aminoacid level in brain, especially increase Glu/GABA.

     

/

返回文章
返回